Russell Investments Group’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956K | Sell |
29,392
-170,198
| -85% | -$5.53M | ﹤0.01% | 2084 |
|
|
2025
Q1 | $7.54M | Buy |
199,590
+91,201
| +84% | +$3.44M | 0.01% | 946 |
|
|
2024
Q4 | $8.87M | Buy |
108,389
+29,442
| +37% | +$2.41M | 0.01% | 866 |
|
|
2024
Q3 | $9.02M | Buy |
78,947
+59,988
| +316% | +$6.85M | 0.01% | 879 |
|
|
2024
Q2 | $1.43M | Buy |
18,959
+101
| +0.5% | +$7.63K | ﹤0.01% | 1806 |
|
|
2024
Q1 | $1.29M | Buy |
+18,858
| New | +$1.29M | ﹤0.01% | 1876 |
|
|
2023
Q3 | – | Sell |
-805
| Closed | -$40.2K | – | 3601 |
|
|
2023
Q2 | $40.2K | Hold |
805
| – | – | ﹤0.01% | 2750 |
|
|
2023
Q1 | $30.2K | Buy |
+805
| New | +$30.2K | ﹤0.01% | 2771 |
|
|
2021
Q1 | – | Sell |
-22,229
| Closed | -$590K | – | 3177 |
|
|
2020
Q4 | $590K | Buy |
+22,229
| New | +$590K | ﹤0.01% | 2359 |
|